| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/06/1992 | US5153310 Il-2 analogs containing n-linked glycosylation sites |
| 10/06/1992 | CA1308515C Peptide derivatives and processes for their preparation |
| 10/06/1992 | CA1308377C Complex of polyethyleneglycol and tissue plasminogen activator |
| 10/06/1992 | CA1308373C Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme or the like |
| 10/04/1992 | CA2064635A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 10/02/1992 | CA2064413A1 Anti-idiotypic monoclonal antibodies |
| 10/01/1992 | WO1992016656A1 Gene mutated in colorectal cancer of humans |
| 10/01/1992 | WO1992016641A1 Process for expressing polypeptide |
| 10/01/1992 | WO1992016631A1 SUCROSE PHOSPHATE SYNTHASE (SPS), ITS PROCESS FOR PREPARATION, ITS cDNA, AND UTILIZATION OF cDNA TO MODIFY THE EXPRESSION OF SPS IN THE PLANT CELLS |
| 10/01/1992 | WO1992016624A1 Monoclonal antibody against lps core |
| 10/01/1992 | WO1992016621A1 Novel beta integrin subunit |
| 10/01/1992 | WO1992016620A1 Human follicle stimulating hormone receptor |
| 10/01/1992 | WO1992016563A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
| 10/01/1992 | WO1992016558A1 Cell surface receptors homologous to coagulation factors v and viii |
| 10/01/1992 | WO1992016557A1 Recombinant human factor viii derivatives |
| 10/01/1992 | WO1992016554A1 Protein allergens of the species cynodon dactylon |
| 10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 10/01/1992 | CA2105993A1 Cell surface receptors homologous to coagulation factors v and viii |
| 10/01/1992 | CA2105876A1 Gene mutated in colorectal cancer of humans |
| 09/30/1992 | WO1992017586A1 Protein having a cytokinin-type activity, recombinant dna coding for this protein, transformed cells and micro-organisms |
| 09/30/1992 | EP0506574A1 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 09/30/1992 | EP0506561A1 Process for enzymatic synthesis of macrolactone |
| 09/30/1992 | EP0506523A2 Monoclonal antibodies |
| 09/30/1992 | EP0506477A1 Vascular endothelial cell growth factor C subunit |
| 09/30/1992 | EP0506326A2 Diequitorially bound beta 1-4 polyuronates and use of same for cytokine stimulation |
| 09/30/1992 | EP0506032A1 Receptor purification method |
| 09/30/1992 | EP0505921A2 Process for the preparation of mature polypeptides by enzymatic cleavage with factor XA |
| 09/30/1992 | EP0505908A1 Chimaeric polypeptides |
| 09/30/1992 | EP0505846A1 Process for converting fused protein into active type human motilin analogues and purifying the analogues |
| 09/30/1992 | EP0505749A2 Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| 09/30/1992 | EP0505566A1 Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
| 09/30/1992 | EP0505387A1 Dna binding proteins including androgen receptor |
| 09/30/1992 | EP0505353A1 Fast printer with a particle trap in the paper channel. |
| 09/30/1992 | EP0307472B1 Immunogenic recombinant yeast expression product and method for purifying it |
| 09/30/1992 | CN1064893A Procedure for hydrolyzing keratin |
| 09/29/1992 | WO1992017568A1 A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER |
| 09/29/1992 | US5151504 Method for purification of monoclonal antibodies |
| 09/29/1992 | US5151350 Cloned genes encoding recombinant protein a |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | CA2106190A1 Cdna clone encoding a human norepinephrine transporter |
| 09/29/1992 | CA2064131A1 Receptor purification method |
| 09/29/1992 | CA2064114A1 Somatostatin receptor |
| 09/29/1992 | CA1308217C Substrate peptides |
| 09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
| 09/23/1992 | WO1992016634A1 A process for producing heme proteins |
| 09/23/1992 | EP0505311A2 A process for producing heme proteins |
| 09/23/1992 | EP0505151A2 Preparation of the penicilline binding protein 2A from staphylococcus aureus 27R, purification and use in a resistant-assay |
| 09/23/1992 | EP0505148A1 Stimulating factor of the neu receptor |
| 09/23/1992 | EP0505034A2 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
| 09/23/1992 | EP0504919A2 Mirabilis jalapa antiviral protein |
| 09/23/1992 | EP0504823A2 Method for producing human serum albumin |
| 09/23/1992 | EP0504798A1 Method of production of high amounts of glutaryl acyclase |
| 09/23/1992 | EP0504388A1 Varicella-zoster virus antigen |
| 09/23/1992 | EP0504363A1 PURIFIED IgG ANTIBODIES |
| 09/23/1992 | EP0504350A1 Antibodies directed against cd3 |
| 09/23/1992 | EP0504327A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/23/1992 | EP0504291A1 Novel proteins with oncostatin m activity and process for their preparation |
| 09/23/1992 | EP0504257A1 [Ala IL-8] 77 AS A LEUKOCYTE ADHESION INHIBITOR |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/23/1992 | EP0504234A1 ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
| 09/23/1992 | EP0504177A1 A mammalian cytokine, il-11 |
| 09/23/1992 | EP0504173A1 Monoclonal antibodies specific for acetyl cholinesterase |
| 09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
| 09/23/1992 | CN1064704A Curculin b and dna encoding same, and process for production thereof |
| 09/23/1992 | CN1064684A Insecticidally effective peptides |
| 09/23/1992 | CA2106485A1 Process for producing heme proteins |
| 09/23/1992 | CA2061507A1 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived thereform |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | US5149783 Polypeptide capable of being cleaved by protease of rhinovirus for use as a test system for inhbitors of viral proteases and an assay for identifying viral inhibitors |
| 09/22/1992 | US5149781 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma |
| 09/22/1992 | US5149777 Human insulin analogs and preparations containing them |
| 09/22/1992 | US5149716 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
| 09/22/1992 | US5149532 Transforming lactobacillus by recombinant DNA technology to express herpes virus glycoprotein D, growing lactobacillus in culture media, harvesting by separation |
| 09/22/1992 | CA1307753C Dna sequences, recombinant dna molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/22/1992 | CA1307752C Immunoaffinity purification system |
| 09/20/1992 | WO1992016546A1 Response element compositions and assays employing same |
| 09/20/1992 | CA2100584A1 Response element compositions and assays employing same |
| 09/20/1992 | CA2063316A1 Dna and amino acid sequence of penicillin binding protein 2a from staphylococcus aureus strain 27r and derivatives for use in purification thereof and assay for compounds effective against methicillin resistant organisms |
| 09/19/1992 | WO1992016658A1 Response element compositions and assays employing same |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2100582A1 Response element compositions and assays employing same |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015699A1 High affinity humanized monoclonal antibodies |
| 09/17/1992 | WO1992015697A1 Pea protein hydrolyzate, method for production thereof and use thereof |
| 09/17/1992 | WO1992015696A1 Method for production of a vegetable protein hydrolyzate and a use thereof |
| 09/17/1992 | WO1992015691A1 Biocidal proteins |
| 09/17/1992 | WO1992015684A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 09/17/1992 | WO1992015677A1 Process for the development of binding mini-proteins |
| 09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
| 09/17/1992 | WO1992015671A1 Soluble cd28 proteins and methods of treatment therewith |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015612A1 Curculin b, dna coding for the same, and production of both of them |
| 09/17/1992 | WO1992015603A1 Prad1 cyclin and its cdna |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015279A1 Cosmetic composition containing at least one purified peptide as active principle obtainable by hydrolysis of casein with opiod activity |
| 09/17/1992 | WO1992015195A1 Insecticidally effective peptides |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | CA2106092A1 Biocidal proteins |
| 09/17/1992 | CA2104595A1 Pea protein hydrolyzate, method for production thereof and use thereof |